Geneos Wealth Management Inc. Clovis Oncology, Inc. Call Options Transaction History
Geneos Wealth Management Inc.
- $2.6 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CLVS
# of Institutions
1Shares Held
166Call Options Held
0Put Options Held
0About Clovis Oncology, Inc.
- Ticker CLVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 144,480,000
- Market Cap $13M
- Description
- Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...